Mar 20, 2017 Checkpoint Therapeutics to Present Preclinical Data at the American Association for Cancer Research Annual Meeting 2017
Feb 28, 2017 Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lung Cancer Compound CK-101